IP Library Granted Patent US 12,076,047
Granted Patent B2
US 12,076,047 · App. 16/938,769 · Granted Sep 3, 2024

Uterine hemorrhage controlling system and method

Inventors: Alexander James Norred (San Luis Obispo, CA); Davis Reed Carlin (Sammamish, WA); George Cochran Harper (Laguna Niguel, CA); David C. Lagrew, Jr. (Irvine, CA); Amelia Michele Degenkolb (San Luis Obispo, CA)
Assignee: Alydia Health, Inc.
A61B17/42A61M1/916A61B17/1204A61B17/12136A61B2017/306A61B2217/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,076,047
App. No.
16/938,769
Granted
Sep 3, 2024
Kind
B2
Abstract

A method of reducing postpartum bleeding includes positioning a device comprising a vacuum element within the uterus; sealing the uterus; activating vacuum in the uterus with the vacuum element of the device while the uterus is sealed; and collapsing the uterus with the vacuum to reduce postpartum bleeding.

Claims (30)

1. A method of reducing postpartum bleeding, comprising:

positioning a device comprising a vacuum element and a sealing element, the vacuum element having a plurality of openings along a circumference thereof and distal to the sealing element such that the sealing element is located within the vaginal canal and the plurality of openings is located within the uterine cavity distal to the vaginal canal;

sealing the uterus with the sealing element;

activating vacuum in the uterine cavity through the openings while the uterine cavity is sealed; and

collapsing the uterine cavity with the vacuum to reduce postpartum bleeding, wherein collapsing the uterus comprises collapsing uterine walls onto a shield of the device so as to prevent obstruction of the plurality of openings.

2. The method of claim 1 , wherein positioning the device comprises transvaginally delivering the vacuum element into the uterus.

3. The method of claim 1 , wherein sealing the uterus comprises placing a seal at the vulva, cervix, or vaginal canal.

4. The method of claim 1 , wherein sealing the uterus comprises expanding a seal against tissue proximate to or within the uterus.

5. The method of claim 4 , wherein expanding the seal comprises delivering fluid to an interior of the seal.

6. The method of claim 1 , wherein activating vacuum comprises activating vacuum with a vacuum pump connected to the vacuum element.

7. The method of claim 1 , wherein activating vacuum comprises producing a negative pressure within the uterus of up to 3 psi.

8. The method of claim 1 , further comprising removing fluid from the uterus after activating vacuum.

9. The method of claim 1 , wherein the step of activating vacuum includes activating vacuum so as to counteract uterine atony.

10. The method of claim 1 , wherein the step of activating vacuum includes activating vacuum so as to facilitate closing of exposed uterine arterioles in a wall of the uterus.

11. The method of claim 1 , further comprising maintaining vacuum until hemorrhaging has substantially stopped.

12. The method of claim 1 , further comprising maintaining vacuum for 1-24 hours.

13. The method of claim 1 , further comprising monitoring a flow of blood out of the uterus while vacuum is activated.

14. The method of claim 13 , wherein monitoring the flow of blood comprises monitoring through a transparent portion of the device.

15. The method of claim 1 , wherein positioning the device at least partially within the uterus comprises positioning at least one opening of the vacuum element within the uterus.

16. A method of reducing postpartum bleeding, comprising:

positioning a device comprising a curved loop vacuum element and a sealing element, the curved loop vacuum element having a plurality of openings positioned along an inner circumference thereof and distal to the sealing element such that the sealing element is located within the vaginal canal and the plurality of openings is located within the uterine cavity distal to the vaginal canal;

sealing the uterus with the sealing element;

activating vacuum in the uterine cavity through the openings of the curved loop vacuum element while the uterine cavity is sealed; and

collapsing the uterine cavity with the vacuum to reduce postpartum bleeding wherein collapsing the uterus comprises collapsing uterine walls onto an outer circumference of the curved loop vacuum element so as to prevent obstruction of the plurality of openings.

17. The method of claim 16 , further comprising reversibly deforming the curved loop vacuum element prior to positioning the curved loop vacuum element within the uterus.

18. A method of reducing postpartum bleeding, comprising:

transvaginally delivering a device into a uterus, the device comprising a set of suction tubes and a sealing element, the set of suction tubes including an outer suction tube having a curved loop portion with plurality of openings positioned along an inner circumference thereof and an inner suction tube having a shorter length than the outer suction tube and having a curved looped portion that is within the outer suction tube, and the set of suction tubes located distal to the sealing element such that the sealing element is located within the vaginal canal and the plurality of openings is located within the uterine cavity distal to the vaginal canal;

sealing the uterus with the sealing element;

transmitting, via the set of suction tubes, a negative pressure to an interior of the uterine cavity while the uterine cavity is sealed; and

collapsing the uterine cavity with the negative pressure wherein collapsing the uterus comprises collapsing uterine walls onto the outer suction tube so as to prevent obstruction of the plurality of openings.

Assignments (11)
SECURITY INTEREST Recorded Feb 27, 2026
From: ALYDIA HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073924/0283 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073647/0789 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073648/0021 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073648/0252 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073648/0473 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2025
From: NORRED, ALEXANDER JAMES; CARLIN, DAVIS REED; HARPER, GEORGE COCHRAN; LAGREW, DAVID C., JR.; SEGNITZ, JAN; DEGENKOLB, AMELIA MICHELE
To: ALYDIA HEALTH, INC.
Reel/Frame 073021/0890 →
SECURITY INTEREST Recorded May 29, 2024
From: ALYDIA HEALTH, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 067545/0844 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT (CREDIT AGREEMENT) Recorded Mar 11, 2022
From: ALYDIA HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 059710/0557 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT (DOLLAR NOTES) Recorded Mar 11, 2022
From: ALYDIA HEALTH, INC.
To: U.S. BANK, NATIONAL ASSOCIATION , AS COLLATERAL AGENT
Reel/Frame 059710/0570 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT (EURO NOTES) Recorded Mar 11, 2022
From: ALYDIA HEALTH, INC.
To: U.S. BANK, NATIONAL ASSOCIATION , AS COLLATERAL AGENT
Reel/Frame 059710/0612 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2020
From: NORRED, ALEXANDER JAMES; CARLIN, DAVIS REED; HARPER, GEORGE COCHRAN; LAGREW, DAVID C., JR.; SEGNITZ, JAN
To: ALYDIA HEALTH, INC.
Reel/Frame 054582/0108 →
Continuity (6)
Continuation In Part 16367068 · Mar 27, 2019
Continuation 16035543 · Jul 13, 2018
Continuation 13827579 · Mar 14, 2013
Continuation In Part 13420871 · Mar 15, 2012
Provisional Application 62878255 · Jul 24, 2019
Related Publication 20200352602A1 · Nov 12, 2020